10th Annual BIO Asia International Conference
Thank you for attending the 10th Annual BIO Asia International Conference!
January 29-30, 2013
Tokyo, Japan
The BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements.
The conference features private, pre-arranged meetings between senior-level executives, using BIO’s proprietary state-of-the-art computer software, BIO One-on-One Partnering. The format and selective nature of the conference makes this the premier dedicated biotech partnering event in Asia and an unrivalled opportunity to meet with the leading international pharmaceutical and biotech companies in one place at one time.
More about One-on-One Partnering events
Regions Represented by Participating Companies
Industries Represented by Participating Companies
Presenting Company Geographic Breakdown
See our 2013 Program & Attendee List*
Thank you to our sponsors!
*Program details subject to change
"I've been looking forward to the BIO Asia International Conference since attending one of the BIO events in China last year. SHL is pleased to have the opportunity to not only introduce our company and products at this conference, but also to exhibit and demonstrate our injection devices to help other attendees better understand the benefits of auto injectors and pen injectors."
-- Steve Kaufman, Marketing Director, SHL Group
Conference News and Updates
- Online Registration now closed. Please complete the Online Registration form and bring it with you at the Grand Hyatt Tokyo, Third Floor.
- New Speakers: Ken Araki of Takeda and David Low of Lazard added to Global Gains panel
- Download the Program Schedule
- See Our Registration Rates. Group Discounts Available!
- Now Accepting Company Presentation Applications
Asia-Pacific Biotech News
- Dezima Pharma In-Licenses CETP Inhibitor Program Fromm Mitsubishi Tanabe Pharma Corporation
- Takeda's R&D Boss Injects 'Urgency' into Japan's No. 1 Drugmaker
- Amgen Plans $200 Million Facility in Singapore
- Ranbaxy, Daiichi Sankyo to Leverage Synergies in Thailand
- TG Enters mAb Therapeutic Agreement for South Korea, SE Asia
BIO looks forward to welcoming many new companies this year:
| A-CLIP Institute, LLC | BeiGene |
| BINEX, Co., Ltd | BioComo, Inc. |
| Bonac Corporation | Cellgentech, Inc. |
| CytoPathfinder, Inc. | EryDel SpA |
| Evec, Inc. | Heptares Therapeutics |
| IMMD, Inc. | Immunogenes |
| Jitsubo Co., Ltd. | Kareus Therapeutics |
| Kaytee Bio, Co. & Ltd. | Microbiotix |
| Neomics | Oncothyreon, Inc. |
| OP BIO Factory Co., Ltd. | Opsona Therapeutics Ltd. |
| Probiodrug AG | SHL Group |
Co-Host
Double Helix Sponsors
Helix Sponsors
Conference Sponsors
Media Partners
